Baixar PDF

Outros usuários também visualizaram estes artigos

DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN TUNISIAN CHRONIC MYELOID LEUKEMIA PATIENTS Rim FRIKHA, Moez ELLOUMI, Hassen KAMOUN
10.1016/j.htct.2023.09.057
Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors N. Lopina, I. Dmytrenko, D. Lopin, D. Hamov, I. Dyagil
10.1016/j.htct.2020.09.035
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice Carla Boquimpani, Fernanda Salles Seguro, Gustavo Henrique Romani Magalhães, Ingrid Luise Soares Pinto, Israel Bendit, Jaisson André Pagnoncelli Bortolini, Katia Borgia Barbosa Pagnano, Renato Centrone, Vaneuza Funke
10.1016/j.htct.2022.04.002